AGT and metabolic dysfunction-associated steatohepatitis: Chymase inhibitor resulted in reductions in the gene expression of the NADPH oxidase component Rac-1 and the oxidative stress marker malondialdehyde in addition to a reduction of angiotensin II levels in a hamster MCD-induced NASH model (Masubuchi et al., 2013).